ISLET CELL ANTIBODIES AND GLUTAMIC ACID DECARBOXYLASE ANTIBODIES IN PATIENTS WITH INSULIN-DEPENDENT DIABETES MELLITUS UNDERGOING KIDNEY AND ISLET-AFTER-KIDNEY TRANSPLANTATION1
Authors:
- Bernhard J. HeringBHBernhard J. Hering
- Thomas DyrbergTDThomas Dyrberg
- Konrad FederlinKFKonrad Federlin
- Reinhard G. BretzelRBReinhard G. Bretzel
- 1 August 1996
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (3) , 424-426
Abstract
The humoral immune response to islet autoantigens, here defined by the presence of islet cell antibodies (ICA) and glutamic acid decarboxylase (GAD 65) antibodies, was studied in patients with long-term insulin-dependent diabetes mellitus (IDDM) receiving immunosuppressive therapy following kidney and islet-after-kidney transplantation. In a cross-sectional study of 30 kidney-grafted, long-term IDDM patients and 30 matched, nontransplanted IDDM controls, we observed a significant (P<0.05) decrease in ICA positivity by standard immunosuppressive therapy, but not in frequency or index levels of GAD 65 antibodies. Because of this intriguing finding, we investigated, in a pilot study on seven islet-after-kidney transplant recipients, the time course of frequency and levels of ICAs and GAD 65 antibodies relative to islet graft function. Stable islet graft function was seen in the patients with low GAD 65 antibody index levels, whereas rapid islet graft failure occurred in a patient with high GAD 65 antibody index levels prior to transplantation. In addition, GAD 65 autoimmunity reoccurred in one pretransplant antibody-negative patient 2 months after graft failure was noted. In conclusion, these observations suggest that beta-cell autoimmunity directed to GAD 65 can persist despite immunosuppressive therapy and may adversely affect islet graft function, possibly indicating disease recurrence as a major threat to successful clinical islet transplantation.Keywords
This publication has 10 references indexed in Scilit:
- Inclusion of peripancreatic lymph node cells prevents recurrent autoimmune destruction of islet transplants: Evidence of donor chimerismSurgery, 1995
- Glutamic Acid Decarboxylase (GAD65) Autoantibodies in Prediction of β-Cell Function and Remission in Recent-Onset IDDM After Cyclosporin TreatmentDiabetes, 1994
- Detection of GAD65 Antibodies in Diabetes and Other Autoimmune Diseases Using a Simple Radioligand AssayDiabetes, 1994
- Clinical Islet Transplantation — Registry Report, Accomplishments in the past and Future Research NeedsCell Transplantation, 1993
- Lack of Predictive Value of Islet Cell Antibodies, Insulin Antibodies, and HLA-DR Phenotype for Remission in Cyclosporin-Treated IDDM PatientsDiabetes, 1990
- Cyclosporin A Suppresses Insulin Autoantibodies and Heterologous Insulin Antibodies in Type I Diabetic ChildrenDiabetes, 1988
- DISAPPEARANCE AND REAPPEARANCE OF ISLET CELL CYTOPLASMIC ANTIBODIES IN CYCLOSPORIN-TREATED INSULIN-DEPENDENT DIABETICSThe Lancet, 1985
- Spontaneous Diabetes in Rats: Destruction of Islets Is Prevented by Immunological ToleranceScience, 1981